I. Introduction
===============

Angiofibroma is a histologically-benign and locally-aggressive vascular tumor that typically originates from the nasopharynx (NA). It represents 0.05% of all head and neck neoplasms[@B1] and mostly affects adolescent males. Angiofibromas outside the NA, extra-nasopharyngeal angiofibromas (ENAF), most frequently involve the maxilla[@B2] but can also be found in the ethmoid, nasal cavities or nasal septum[@B3], although these localizations are uncommon. Characteristics of ENAF tend to be quite different from an angiofibroma of the NA, including patient gender[@B4][@B5], patient age[@B2], prevalence, affected site, pathogenesis, and clinical and epidemiological features[@B6][@B7], and some authors classify ENAF as a different disease[@B8][@B9]. Although management of ENAF is not fully codified, imaging, endoscopy, and clinical features are extremely helpful in diagnosis, and embolization has been used in selected cases[@B10].

Since the clinical characteristics of ENAF do not conform with those of the more common NA, these tumors could present a diagnostic challenge[@B11]. More often than not, epistaxis is the presenting sign[@B9], but nasal obstruction, pain, hyposmia and progressive swelling of the nose have also been reported[@B7].

The computed tomography (CT) scan has been considered the preferred radiological exam for many years[@B12][@B13][@B14], and magnetic resonance imaging (MRI) is used to determine the tumor site and extension[@B11].

Various therapeutic approaches have been proposed, including radiotherapy (RT)[@B8], endoscopic surgery, and preoperative embolization. The majority of arteriovenous malformations, including ENAF, are treated with embolization of the hypervascular lesion during arteriography combined with surgical treatment[@B4][@B15]. Surgery is generally considered the best treatment modality[@B11][@B16]. However, vascular intranasal tumors might be difficult to treat, and selective embolization is recommended in cases of tumors reaching a large volume, which tends to make the procedure complex and bloody[@B10].

Under general anesthesia an endoscopic and endonasal removal should be attempted[@B18], although excessive bleeding could require an external incision[@B10][@B19]. Additionally, electrical cauterization might not suffice, thus an abrasion from the submucosal to the sub-perichondral area should be performed[@B20]. Recurrence of ENAF is rare[@B10][@B11].

II. Case Report
===============

A 28-year-old man was referred from the emergency room (ER) of the S.M. alle Scotte University Hospital of Siena to the ENT Clinic for profuse nasal bleeding from the right nostril in February 2017.

After suction and removal of several blood clots, physical examination revealed a right-sided lobulated mass in the right nasal fossa. The patient reported that fifteen days prior to presentation, he dove into a pool and afterwards suffered airflow impairment and recurrent dripping of blood from that nostril. He could not recall previous episodes of epistaxis, not even as a child, and he did not complain about nasal pain, neck swelling or hearing impairment.

The patient\'s clinical history was negative for recent illnesses and familiar pathologies, drugs and medication consumption (neither habitually nor in the previous month), cocaine use, smoking and exposure to nasal irritants. Moreover, he was in good physical shape; he practiced swimming twice a week, and he was a blood donor. According to the standard procedure to donate in Italy, he had recently (3 months earlier) submitted to blood testing and electrocardiography. No anemia, alterations of blood coagulation or other anomalies had been detected. His blood tests, repeated in the ER, showed a slight impairment of hemoglobin and hematocrit, although this was not relevant.

After spontaneous interruption of bleeding, the fibroscopic examination was conducted through the left nostril only (to avoid further bleeding from the mass) and did not reveal any anomalies in the NA or the larynx. No neck masses could be detected through palpation.

A CT scan of the head and neck was prescribed ([Fig. 1](#F1){ref-type="fig"}), and the radiologist reported an "inhomogeneous solid lesion (post-traumatic scab? polypoid formation?) in the right nasal fossa to be further studied with MRI with contrast...".

An absorbable gauze was delicately put into the right nostril, and an MRI scan was scheduled for five weeks, the first available date.

Three days following his initial presentation and examination, the patient was re-evaluated by an otolaryngologists. The patient did not report any further bleeding, and the absorbable gauze was removed. The physical and endoscopic examination (this time also conducted through the right nostril) revealed the mass had considerably diminished in size (less than 0.5 cm), and no active bleeding points were visible.

Despite the otolaryngologist\'s recommendation, the patient firmly refused further treatment or examination. Therefore, he was dismissed but agreed to return for another appointment the following week.

The night before the second planned follow-up, the patient returned for profuse bleeding from the right nostril accompanied with complete blockage of airflow, right-sided nasal swelling, anxiety and panic. Upon physical examination, the right nostril was completely occluded works by a reddish-yellow mass that bled easily.([Fig. 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}) We admitted him to our clinic and administered mild sedatives, antibiotics, and tranexamic acid. Fortunately, the nasal bleeding stopped and the patient calmed down. Surgery was planned for the following morning. The MRI scan could not be done due to the short notice.

With the patient under general anesthesia, the formation situated in the anterior portion of the right side of the nasal septum was removed up to its vascular base and sent for a histological examination. Although electrical cauterization efficiently controlled the bleeding ([Fig. 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}), we decided to perform an abrasion of the sub-perichondral area to prevent further bleeding and recurrence. Finally, through a 0° and a 30° endoscope, we performed an inspection of the nasal cavities, identifying a mild swelling in the posterior wall of the NA. Thus, the tissue was biopsied, and the specimen was sent for the histological examination as well.

Two 8-cm-long sponges were applied in the nasal fossa. The patient\'s postoperative recovery was uneventful, and he was discharged without any complications the following day. The nasal pack was removed within three days of the intervention, and the nasal inspection revealed normal postoperative healing.

The histological exam report read "hyperplasia of the lymphatic tissue with active germinative centers" for the nasopharyngeal tissue, and "angiofibroma" ([Fig. 6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"}) for the nasal septum mass.

The patient returned for three follow-up appointments at two weeks postoperative, one month later and, finally, six months after surgery. Until now, no recurrence or other nasal anomalies have been visible.

III. Discussion
===============

Since the characteristics of an angiofibroma originating from the nasal septum completely differ from the characteristics of an angiofibroma localized in the NA and because of our experience, we agree with Tasca and Compadretti[@B11] that the different designation "extra-nasopharyngeal angiofibroma" should be used to correctly identify these lesions.

The nasal septum is an extremely rare site for ENAF, and, to date, there are less than 30 reported cases in the scientific literature[@B7], beginning with Hiraide and Matsubara[@B17] in 1984.

As commonly occurs, epistaxis was the presenting sign of the angiofibroma in our case. However, the onset was unusual, because the bleeding was caused by a dive in a swimming pool, a low impact trauma. In addition, the patient in this case had a significant amount of anxiety from the nasal swelling and breathing impairment.

Despite being uncommon, nasal septal angiofibromas should be considered during the evaluation and treatment of epistaxis. Although the histological examination confirms the diagnosis, ENAF can be effectively managed in an early timeframe with an objective examination through the fiberscope, the CT scan, as well as carefully collecting the anamnesis.

In addition, the MRI provides further preoperative information regarding the necessity of embolization to reduce the risk of bleeding during the procedure. However, we decided not to wait for the scan in our case since the first available appointment was one month later, and we proceeded with surgery as soon as possible for multiple indications. First of all, we did not want the lesion to grow, as vascular tumors are more difficult to treat if they reach a large volume and extend towards adjacent areas. Secondly, we did not want to inconvenience such a young and active patient with physical restrictions (by avoiding sport and exertion) and potentially dangerous and uncomfortable conditions (anemia, airflow impairment, nasal blockage) for a long period of time. Last but not least, we intended to prevent further psychological distress and other episodes of panic attacks which impeded his cooperation during the bleeding episodes and may cause his refusal to undergo further examinations or procedures, a situation that occurred during the first follow-up.
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![Endoscopic view of the nasal fossa after surgical removal of the angiofibroma.](jkaoms-45-43-g004){#F4}
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